Annual FCF
-$52.33 M
-$5.90 M-12.71%
31 December 2023
Summary:
Jasper Therapeutics annual free cash flow is currently -$52.33 million, with the most recent change of -$5.90 million (-12.71%) on 31 December 2023. During the last 3 years, it has fallen by -$34.07 million (-186.49%). JSPR annual FCF is now -186.49% below its all-time high of -$18.27 million, reached on 31 December 2020.JSPR Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$14.33 M
-$2.49 M-21.03%
30 September 2024
Summary:
Jasper Therapeutics quarterly free cash flow is currently -$14.33 million, with the most recent change of -$2.49 million (-21.03%) on 30 September 2024. Over the past year, it has dropped by -$2.35 million (-19.57%). JSPR quarterly FCF is now -135.70% below its all-time high of -$6.08 million, reached on 30 June 2021.JSPR Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$58.63 M
-$2.35 M-4.17%
30 September 2024
Summary:
Jasper Therapeutics TTM free cash flow is currently -$58.63 million, with the most recent change of -$2.35 million (-4.17%) on 30 September 2024. Over the past year, it has dropped by -$10.28 million (-21.26%). JSPR TTM FCF is now -719.47% below its all-time high of -$7.16 million, reached on 31 March 2021.JSPR TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JSPR Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -12.7% | -19.6% | -21.3% |
| 3 y3 years | -186.5% | -89.0% | -181.7% |
| 5 y5 years | - | - | - |
JSPR Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -186.5% | at low | -89.0% | +14.3% | -181.7% | at low |
| 5 y | 5 years | -186.5% | at low | -135.7% | +14.3% | -719.5% | at low |
| alltime | all time | -186.5% | at low | -135.7% | +14.3% | -719.5% | at low |
Jasper Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$14.33 M(+21.0%) | -$58.63 M(+4.2%) |
| June 2024 | - | -$11.84 M(-24.9%) | -$56.29 M(-2.5%) |
| Mar 2024 | - | -$15.76 M(-5.7%) | -$57.73 M(+10.3%) |
| Dec 2023 | -$52.33 M(+12.7%) | -$16.71 M(+39.5%) | -$52.33 M(+8.2%) |
| Sept 2023 | - | -$11.98 M(-9.8%) | -$48.35 M(+4.6%) |
| June 2023 | - | -$13.28 M(+28.2%) | -$46.24 M(+8.7%) |
| Mar 2023 | - | -$10.36 M(-18.6%) | -$42.55 M(-8.4%) |
| Dec 2022 | -$46.43 M | -$12.73 M(+29.0%) | -$46.43 M(-5.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$9.87 M(+2.8%) | -$49.00 M(+4.9%) |
| June 2022 | - | -$9.60 M(-32.6%) | -$46.71 M(+8.2%) |
| Mar 2022 | - | -$14.24 M(-6.9%) | -$43.19 M(+19.6%) |
| Dec 2021 | -$36.11 M(+97.7%) | -$15.29 M(+101.8%) | -$36.11 M(+73.5%) |
| Sept 2021 | - | -$7.58 M(+24.7%) | -$20.81 M(+57.3%) |
| June 2021 | - | -$6.08 M(-15.1%) | -$13.23 M(+84.9%) |
| Mar 2021 | - | -$7.16 M | -$7.16 M |
| Dec 2020 | -$18.27 M | - | - |
FAQ
- What is Jasper Therapeutics annual free cash flow?
- What is the all time high annual FCF for Jasper Therapeutics?
- What is Jasper Therapeutics annual FCF year-on-year change?
- What is Jasper Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Jasper Therapeutics?
- What is Jasper Therapeutics quarterly FCF year-on-year change?
- What is Jasper Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Jasper Therapeutics?
- What is Jasper Therapeutics TTM FCF year-on-year change?
What is Jasper Therapeutics annual free cash flow?
The current annual FCF of JSPR is -$52.33 M
What is the all time high annual FCF for Jasper Therapeutics?
Jasper Therapeutics all-time high annual free cash flow is -$18.27 M
What is Jasper Therapeutics annual FCF year-on-year change?
Over the past year, JSPR annual free cash flow has changed by -$5.90 M (-12.71%)
What is Jasper Therapeutics quarterly free cash flow?
The current quarterly FCF of JSPR is -$14.33 M
What is the all time high quarterly FCF for Jasper Therapeutics?
Jasper Therapeutics all-time high quarterly free cash flow is -$6.08 M
What is Jasper Therapeutics quarterly FCF year-on-year change?
Over the past year, JSPR quarterly free cash flow has changed by -$2.35 M (-19.57%)
What is Jasper Therapeutics TTM free cash flow?
The current TTM FCF of JSPR is -$58.63 M
What is the all time high TTM FCF for Jasper Therapeutics?
Jasper Therapeutics all-time high TTM free cash flow is -$7.16 M
What is Jasper Therapeutics TTM FCF year-on-year change?
Over the past year, JSPR TTM free cash flow has changed by -$10.28 M (-21.26%)